Hanover Insurance Group (THG) Tops Q2 EPS by 25c, Revenues Beat
Get Alerts THG Hot Sheet
Financial Fact:
Weighted average shares outstanding: 42.7M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Hanover Insurance Group (NYSE: THG) reported Q2 EPS of $2.31, $0.25 better than the analyst estimate of $2.06. Revenue for the quarter came in at $1.36 billion versus the consensus estimate of $1.34 billion.
"We are pleased with our second quarter performance," said John C. Roche, president and chief executive officer at The Hanover. "We continued to demonstrate the value of our company's agency-centered strategy and distinctive business model, generating an operating return on average equity of approximately 13 percent(4) and overall growth of 7 percent, notably, in our most profitable businesses.
"While market conditions continue to be very dynamic, we remain satisfied with the overall domestic pricing environment," Roche said. "Our Core Commercial pricing ticked up in the quarter, while Personal Lines rate increases remained relatively stable. We are confident that our dedicated teams, enhanced capabilities and strong agency franchise approach will allow us to continue growing profitably in target sectors."
"For the quarter, we delivered solid operating earnings of $2.20 per share," said Jeffrey M. Farber, executive vice president and chief financial officer. "All of our financial measures remain in line with our expectations. Our current year underlying loss trends remained stable, the expense ratio improved by half-a-point in our domestic business, while retention and new business quality remained strong. We continue to build momentum across the organization, and we are well positioned to capitalize on this momentum in the second half of 2018."
For earnings history and earnings-related data on Hanover Insurance Group (THG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, Guidance, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share